27. C. Packer, A. E. Pusey, Nature 296, 740 (1982 The mammalian ovarian follicle consists of a multilayered complex of somatic cells that surround the oocyte. A signal from the follicle cells keeps the oocyte cell cycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the follicle cells to release the arrest, causing meiosis to continue. Here we show that meiotic arrest can be released in mice by microinjecting the oocyte within the follicle with an antibody that inhibits the stimulatory heterotrimeric GTP-binding protein G s . This indicates that G s activity in the oocyte is required to maintain meiotic arrest within the ovarian follicle and suggests that the follicle may keep the cell cycle arrested by activating G s .
Oocytes within mammalian ovarian follicles begin meiosis during embryogenesis but then arrest at prophase of meiosis I until luteinizing hormone acts on the follicle to cause meiosis to resume (1) . Maintaining this arrest in fully grown oocytes depends on the presence of the surrounding follicle ( Fig. 1 , A and C); removing the oocyte from the follicle reinitiates meiosis. However, it is unknown how the follicle cells communicate with the oocyte to keep the cell cycle arrested. Signaling depends on maintaining a high level of adenosine 3Ј,5Ј-monophosphate (cAMP) in the oocyte, but where the cAMP comes from and how the follicle cells regulate its level is unclear (1). One hypothesis is that cAMP enters the oocyte through gap junctions with the follicle cells (1, 2) . Alternatively, cAMP could be generated in the oocyte, and the role of the follicle cells could be to maintain the activity of a stimulatory G protein (G s ) in the oocyte membrane, thus stimulating oocyte adenylyl cyclase (1, 3) . Although some evidence has been obtained for each model, neither possibility has been definitively tested.
Studies of how meiotic arrest is main- tained and released in mammalian oocytes have been limited by a technical problem: the oocyte is embedded in multiple layers of cells that must be left intact to preserve normal regulation. Here, we developed a method for injecting meiotically competent mouse oocytes within antral follicles (260 to 470 m diameter). The follicle was slightly compressed between two coverslips separated by a 300-m spacer; this assembly was mounted over a reservoir of medium on a support slide with a coverslip base (Fig. 1B) (4, 5) . The chamber was open at the front to allow introduction of a micropipette. The nucleus (germinal vesicle; GV) could be seen in favorable cases, and the nucleolus was always visible (Fig.  1C) . The success of the injection was confirmed by including a fluorescent dextran in the injection solution (Fig. 1D) .
To examine whether a G s protein within the oocyte is required to maintain meiotic arrest within the follicle, we microinjected oocytes with an affinity-purified antibody that inhibits G s function (4, (6) (7) (8) . This antibody was made against the COOHterminal 10 amino acids of the ␣ subunit of G s and specifically recognized both the long and the short forms of G s (9) in isolated oocytes (Fig. 2A) . The amount of G s protein in oocytes was comparable to that in brain ( Fig. 2A) , which indicates that G s is present at a physiologically significant level.
The G s antibody caused resumption of meiosis in follicle-enclosed oocytes, as indicated by light microscopic observation that GV breakdown (GVBD) had occurred in oocytes that were removed from their follicles 3 hours after injection (Fig. 2B) . The intracellular concentration of the G s antibody required to cause GVBD in 50% of the oocytes was between 0.3 and 1.3 M. Antibodyinjected oocytes that underwent GVBD subsequently formed a first polar body (Fig. 2C) , which indicates that meiosis progressed normally (14 of 16 oocytes observed).
Control oocytes that were injected with an antibody (6.7 M) against another G protein, G i3 (6 ) (Fig. 2A) , and other control oocytes that were not injected were GV intact when removed from their follicles 3 hours after injection (Fig. 2, B and D) . The G i antibody-injected oocytes, as well as control uninjected oocytes, underwent GVBD by 3 hours after removal from the follicle, which indicates that the G i antibody itself had no detectable effect on oocyte maturation.
These experiments indicated that inhibition of G s in the oocyte is sufficient to release meiotic arrest and, conversely, that G s activity in the oocyte is required to maintain meiotic arrest within the follicle. Because the ϳ150-kD antibody is too large to pass into follicle cells through gap junctions, which generally have a permeability limit of ϳ1 kD (10), the antibody's inhibitory action must be on G s in the oocyte and not in the follicle cells. It is possible, however, that cAMP entering the oocyte through gap junctions also contributes to the maintenance of meiotic arrest.
Oocytes that are removed from their follicles and maintained in a cAMP phosphodiesterase inhibitor such as hypoxanthine stay arrested at meiotic prophase (1, 3, 4 ) , which suggests that isolated oocytes might have enough G s activity to keep cAMP elevated if its hydrolysis is prevented. To examine this, we injected isolated oocytes with the G s antibody and cultured them in the presence of hypoxanthine. GVBD occurred in these oocytes but not in controls injected with the G i antibody (Fig.  2E) , which indicates that, even in the absence of an intact follicle, at least some G s activity remains in the oocyte (4 ). Additional controls showed that the G s antibody did not cause GVBD by an action downstream of cAMP and that G s antibodymatured oocytes responded normally to fertilization (4 ) (fig. S1) .
G s alone has little constitutive activity (11), which suggests that G s activity in the oocyte might be maintained by a G s -linked receptor in the oocyte membrane. Because Gprotein-linked receptors can have high constitutive activity (12, 13) , this could potentially account for the G s activity in isolated oocytes. In the intact follicle, a ligand might activate such a receptor further, possibly explaining the maintenance of meiotic arrest by the follicular environment (4). It is also possible that G s activity in the oocyte is the same regardless of whether the follicle is present and that the meiosis-inhibiting signal from the follicle acts at another level of the cAMP pathway-for example, to suppress cAMP phosphodiesterase activity in the oocyte (1, 14) .
Comparing these findings with previous studies of frog (Xenopus laevis) oocytes, in which the same G s antibody was found to cause GVBD (8) , indicates that G s activity may be a conserved mechanism for maintaining meiotic arrest in vertebrate oocytes (4 ) (fig. S2) . A difference between mouse and Xenopus, however, is that Xenopus oocytes do not undergo spontaneous GVBD when removed from their follicles. This could be due to species differences in the level of constitutive activity of G s -linked receptors in the oocyte membrane or of phosphodiesterase activity in the oocyte. By identifying oocyte G s as a required factor in maintaining meiotic arrest, our results open the way for future investigations of signaling molecules from the follicle that maintain meiotic arrest in the oocyte as well as the mechanism by which luteinizing hormone causes the resumption of meiosis. Signal recognition particle (SRP), together with its receptor (SR), mediates the targeting of ribosome-nascent chain complexes to the endoplasmic reticulum. Using protein cross-linking, we detected distinct modes in the binding of SRP to the ribosome. During signal peptide recognition, SRP54 is positioned at the exit site close to ribosomal proteins L23a and L35. When SRP54 contacts SR, SRP54 is rearranged such that it is no longer close to L23a. This repositioning may allow the translocon to dock with the ribosome, leading to insertion of the signal peptide into the translocation channel.
Secretory proteins are synthesized with an NH 2 -terminal hydrophobic signal peptide, which is recognized by the SRP as it emerges from the ribosome (1, 2) . SRP targets the ribosome, together with the associated nascent chain, to the endoplasmic reticulum (ER) via 
